Corium

Member

Corium, Inc., is a commercial-stage biopharmaceutical company leading the development and commercialization of novel CNS therapies providing physicians with innovative treatment options for patients, their families, and their caregivers. Corium is commercializing AZSTARYS® and ADLARITY®, each approved by the U.S. FDA. ADLARITY incorporates CORPLEXTM transdermal technology, which has the goal of optimizing clinical benefits for patients by delivering continuous, controlled, and sustained release of a drug over a defined time through the skin. Corium has a pipeline portfolio including a focus on developing other CNS therapies using CORPLEX technology. For further information, please visit http://www.corium.com